Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PLAU | P00749 | 1/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.55 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.54 |
| ▸ | STS | P08842 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248073 | 0.93 | NPC1 (0.73) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL457954 | 0.91 | NPC1 (0.73) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL1694670 | 0.90 | NPC1 (0.63) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL10694377 | 0.88 | SRD5A2 (0.68) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL6208174 | 0.86 | L3MBTL1 (0.70) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL1419819 | 0.86 | L3MBTL1 (0.70) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL28438923 | 0.85 | RAB9A (0.61) | USP2TP53NPC1RAB9AHTT | |
| SCHEMBL9541930 | 0.85 | SRD5A2 (0.62) | USP2TP53L3MBTL1MAPTPLAU | |
| Methoxymethane SCHEMBL27486318 | 0.85 | MAPT (0.63) | USP2TP53NPC1RAB9ALMNA | |
| SCHEMBL27572327 | 0.85 | ALDH1A1 (0.63) | USP2TP53NPC1RAB9AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697053-A | Biocide composition | 巴斯夫欧洲公司 | 2023-02-03 | — | — | CN | claimed |
| CN-111170856-B | Preparation method and application of fluoroolefin | 云南民族大学 | 2022-04-15 | — | — | CN | claimed |
| CN-112426884-A | Antibacterial composite reverse osmosis membrane and preparation method thereof | 嘉兴市爵拓科技有限公司 | 2021-03-02 | — | — | CN | claimed |
| US-8815940-B2 | Coumarin-chalcones as anticancer agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-08-26 | — | — | US | claimed |
| US-20130210909-A1 | COUMARIN-CHALCONES AS ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-08-15 | — | — | US | claimed |
| EP-2601183-A1 | COUMARIN-CHALCONES AS ANTICANCER AGENTS | Council Of Scientific & Industrial Research (IN) | 2013-06-12 | — | — | EP | claimed |
| WO-2012017454-A1 | COUMARIN-CHALCONES AS ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-02-09 | — | — | WO | claimed |
| US-5648159-A | Dry resist | DIAFOIL HOECHST COMPANY, LTD. (JP) | 1997-07-15 | — | — | US | claimed |
| US-20250002519-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | UNIV YALE (US) | 2025-01-02 | — | — | US | disclosed |
| CN-118006232-B | Anti-collision protective film and preparation method thereof | 深圳市精恒光电科技有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| US-12071445-B2 | Precatalyst scaffolds for cross-coupling reactions, and methods of making and using same | YALE UNIVERSITY (US) | 2024-08-27 | — | — | US | disclosed |
| EP-3845546-B1 | COMPLEXES | JOHNSON MATTHEY PLC (GB) | 2024-06-19 | — | — | EP | disclosed |
| EP-3842421-B1 | COMPLEXES | JOHNSON MATTHEY PLC (GB) | 2024-06-12 | — | — | EP | disclosed |
| EP-0587670-A1 | PCP RECEPTOR LIGANDS AND THE USE THEREOF | STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON (US) | 1994-03-23 | — | — | EP | disclosed |
| WO-1992019621-A1 | PCP RECEPTOR LIGANDS AND THE USE THEREOF | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE, OREGON (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0029105-B1 | RADIATION CURABLE COATING COMPOSITION, PROCESS FOR COATING A SUBSTRATE THEREWITH, EYEGLASSES AND LAMINATE | GAF CORPORATION (US) | 1986-02-05 | — | — | EP | disclosed |
| US-4557996-A | Method for providing a pattern-wise photoresist layer on a substrate plate and a surface-protected substrate plate therefor | PHOTOPOLY OHKA CO., LTD. (JP) | 1985-12-10 | — | — | US | disclosed |
| US-4319811-A | OF TRIACRYLATES AND N-BINYL IMIDO GROUP | GAF CORPORATION (US) | 1982-03-16 | — | — | US | disclosed |
| EP-0029105-A2 | Radiation curable coating composition, process for coating a substrate therewith, eyeglasses and laminate | GAF CORPORATION (US) | 1981-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002519-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | TIMCC, YAP1, TET2 | USP2 1344/4885TP53 258/4885NPC1 4247/4885 |
| US-20130210909-A1 | COUMARIN-CHALCONES AS ANTICANCER AGENTS | HCCS, XPO5, CIAPIN1 | USP2 4651/4885TP53 43/4885NPC1 148/4885 |
| US-12071445-B2 | Precatalyst scaffolds for cross-coupling reactions, and methods of making and using same | TIMCC, YAP1, TET2 | USP2 1566/4885TP53 177/4885NPC1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.